COVID-19 Vaccine

Merah Putih

Developed by advanced research programs involving the collaboration of prominent institutes.

Advance

Research Program

 70%

Aiming at Vaccination

Vaccine Platform
Rocombinant Protein Eijkman Institute for Molecular Biology
Recombinant Protein Indonesian Institute of Sciences
DNA - mRNA Universitas Indonesia
Inactivated Virus Universitas Airlangga
Recombinant Protein Universitas Gadjah Mada
Adenoviral Vector Institut Teknologi Bandung
Recombinant Protein Universitas Padjadjaran

Developed by Advanced Research Programs

Involving the collaboration of prominent institutes led by the Eijkman Institute for Molecular Biology.

Developed by dedicated Indonesian scientists
Based on the SARS-CoV-2 virus that circulates in Indonesia.

The whole genome sequences are submitted to GISAID

The world's largest epidemic and pandemic virus database